Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Timms

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Thorax|June 12, 2015
Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu)Adrian R Martineau, Yasmeen Hanifa, Karolina D Witt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast CancerSteven J Isakoff, Erica L Mayer, Lei He, et al.
Genome Medicine|December 19, 2024
Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparibAlan Barnicle, Isabelle Ray-Coquard, Etienne Rouleau, et al.
American Journal of Human Genetics|May 13, 2008
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritisAna M Valdes, John Loughlin, Kirsten M Timms, et al.
Genes and Immunity|December 13, 2006
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritisS Steer, V Abkevich, A Gutin, et al.
Breast Cancer Research and Treatment|May 27, 2015
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)Virginia G Kaklamani, Jacqueline S Jeruss, Elisha Hughes, et al.
The Lancet. Oncology|January 9, 2023
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trialEve Rodler, Priyanka Sharma, William E Barlow, et al.
The Oncologist|March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and AssaysMark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Plos Pathogens|July 16, 2013
Ethnic variation in inflammatory profile in tuberculosisAnna K Coussens, Robert J Wilkinson, Vladyslav Nikolayevskyy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2017
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStephanie Lheureux, Zhongwu Lai, Brian A Dougherty, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Thorax|June 12, 2015
Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu)Adrian R Martineau, Yasmeen Hanifa, Karolina D Witt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast CancerSteven J Isakoff, Erica L Mayer, Lei He, et al.
Genome Medicine|December 19, 2024
Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparibAlan Barnicle, Isabelle Ray-Coquard, Etienne Rouleau, et al.
American Journal of Human Genetics|May 13, 2008
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritisAna M Valdes, John Loughlin, Kirsten M Timms, et al.
Genes and Immunity|December 13, 2006
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritisS Steer, V Abkevich, A Gutin, et al.
Breast Cancer Research and Treatment|May 27, 2015
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)Virginia G Kaklamani, Jacqueline S Jeruss, Elisha Hughes, et al.
The Lancet. Oncology|January 9, 2023
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trialEve Rodler, Priyanka Sharma, William E Barlow, et al.
The Oncologist|March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and AssaysMark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Plos Pathogens|July 16, 2013
Ethnic variation in inflammatory profile in tuberculosisAnna K Coussens, Robert J Wilkinson, Vladyslav Nikolayevskyy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2017
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStephanie Lheureux, Zhongwu Lai, Brian A Dougherty, et al.
Pageof 18